Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783603850> ?p ?o ?g. }
- W2783603850 endingPage "e110" @default.
- W2783603850 startingPage "e109" @default.
- W2783603850 abstract "Although the global prevalence of cigarette smoking has declined, the proportion of people living with HIV who are smokers remains high and is about double that in the general population. 1 Mdodo R Frazier EL Dube SR et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015; 162: 335-344 Crossref PubMed Scopus (302) Google Scholar Despite the high prevalence, the research examining smoking cessation in people living with HIV is surprisingly sparse. 2 Pool ER Dogar O Lindsay RP Weatherburn P Siddiqi K Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016; 6 (CD011120) Google Scholar Thus, the study by Mercié and colleagues, 3 Mercié P Arsandaux J Katlama C et al. Efficacy and safety of varenicline for smoking cessation among people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Lancet HIV. 2018; (published online Jan 9. http://dx.doi.org/10.1016/S2352-3018(18)30002-X) Summary Full Text Full Text PDF PubMed Scopus (36) Google Scholar reported in The Lancet HIV, is a notable contribution. This double-blind, placebo-controlled phase 3 clinical trial showed that a 3 month course of varenicline combined with smoking cessation counselling was associated with a significantly higher proportion of participants who were biochemically confirmed as abstinent at 48 weeks compared with placebo and counselling (18 [15%, 95% CI 8–21] of 123 patients in the varenicline group vs eight [6%, 95% CI 2–11] of 124 patients in the placebo group; p=0·036). The study is the first high-quality investigation showing a long-term benefit of a smoking cessation intervention in HIV. 2 Pool ER Dogar O Lindsay RP Weatherburn P Siddiqi K Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016; 6 (CD011120) Google Scholar Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trialVarenicline is safe and efficacious for smoking cessation in people living with HIV and should be recommended as the standard of care. Full-Text PDF" @default.
- W2783603850 created "2018-01-26" @default.
- W2783603850 creator A5028580215 @default.
- W2783603850 creator A5040238670 @default.
- W2783603850 date "2018-03-01" @default.
- W2783603850 modified "2023-09-27" @default.
- W2783603850 title "Smoking and HIV: confronting the epidemic" @default.
- W2783603850 cites W1985393118 @default.
- W2783603850 cites W1985454368 @default.
- W2783603850 cites W2033875947 @default.
- W2783603850 cites W2034026922 @default.
- W2783603850 cites W2055962849 @default.
- W2783603850 cites W2066804732 @default.
- W2783603850 cites W2128476072 @default.
- W2783603850 cites W2131695868 @default.
- W2783603850 cites W2157138119 @default.
- W2783603850 cites W2340896985 @default.
- W2783603850 cites W2742878865 @default.
- W2783603850 cites W2756153051 @default.
- W2783603850 cites W2783979258 @default.
- W2783603850 doi "https://doi.org/10.1016/s2352-3018(18)30001-8" @default.
- W2783603850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29329762" @default.
- W2783603850 hasPublicationYear "2018" @default.
- W2783603850 type Work @default.
- W2783603850 sameAs 2783603850 @default.
- W2783603850 citedByCount "6" @default.
- W2783603850 countsByYear W27836038502018 @default.
- W2783603850 countsByYear W27836038502019 @default.
- W2783603850 countsByYear W27836038502021 @default.
- W2783603850 countsByYear W27836038502023 @default.
- W2783603850 crossrefType "journal-article" @default.
- W2783603850 hasAuthorship W2783603850A5028580215 @default.
- W2783603850 hasAuthorship W2783603850A5040238670 @default.
- W2783603850 hasConcept C118552586 @default.
- W2783603850 hasConcept C126322002 @default.
- W2783603850 hasConcept C142724271 @default.
- W2783603850 hasConcept C144024400 @default.
- W2783603850 hasConcept C149923435 @default.
- W2783603850 hasConcept C17744445 @default.
- W2783603850 hasConcept C199539241 @default.
- W2783603850 hasConcept C204787440 @default.
- W2783603850 hasConcept C27081682 @default.
- W2783603850 hasConcept C27415008 @default.
- W2783603850 hasConcept C2776939746 @default.
- W2783603850 hasConcept C2776983459 @default.
- W2783603850 hasConcept C2777053506 @default.
- W2783603850 hasConcept C2777843972 @default.
- W2783603850 hasConcept C2779473830 @default.
- W2783603850 hasConcept C2779496540 @default.
- W2783603850 hasConcept C2908647359 @default.
- W2783603850 hasConcept C3013748606 @default.
- W2783603850 hasConcept C512399662 @default.
- W2783603850 hasConcept C535046627 @default.
- W2783603850 hasConcept C71924100 @default.
- W2783603850 hasConcept C74909509 @default.
- W2783603850 hasConcept C83867959 @default.
- W2783603850 hasConcept C99454951 @default.
- W2783603850 hasConceptScore W2783603850C118552586 @default.
- W2783603850 hasConceptScore W2783603850C126322002 @default.
- W2783603850 hasConceptScore W2783603850C142724271 @default.
- W2783603850 hasConceptScore W2783603850C144024400 @default.
- W2783603850 hasConceptScore W2783603850C149923435 @default.
- W2783603850 hasConceptScore W2783603850C17744445 @default.
- W2783603850 hasConceptScore W2783603850C199539241 @default.
- W2783603850 hasConceptScore W2783603850C204787440 @default.
- W2783603850 hasConceptScore W2783603850C27081682 @default.
- W2783603850 hasConceptScore W2783603850C27415008 @default.
- W2783603850 hasConceptScore W2783603850C2776939746 @default.
- W2783603850 hasConceptScore W2783603850C2776983459 @default.
- W2783603850 hasConceptScore W2783603850C2777053506 @default.
- W2783603850 hasConceptScore W2783603850C2777843972 @default.
- W2783603850 hasConceptScore W2783603850C2779473830 @default.
- W2783603850 hasConceptScore W2783603850C2779496540 @default.
- W2783603850 hasConceptScore W2783603850C2908647359 @default.
- W2783603850 hasConceptScore W2783603850C3013748606 @default.
- W2783603850 hasConceptScore W2783603850C512399662 @default.
- W2783603850 hasConceptScore W2783603850C535046627 @default.
- W2783603850 hasConceptScore W2783603850C71924100 @default.
- W2783603850 hasConceptScore W2783603850C74909509 @default.
- W2783603850 hasConceptScore W2783603850C83867959 @default.
- W2783603850 hasConceptScore W2783603850C99454951 @default.
- W2783603850 hasIssue "3" @default.
- W2783603850 hasLocation W27836038501 @default.
- W2783603850 hasLocation W27836038502 @default.
- W2783603850 hasOpenAccess W2783603850 @default.
- W2783603850 hasPrimaryLocation W27836038501 @default.
- W2783603850 hasRelatedWork W1547289621 @default.
- W2783603850 hasRelatedWork W1596834073 @default.
- W2783603850 hasRelatedWork W1975973593 @default.
- W2783603850 hasRelatedWork W2170867476 @default.
- W2783603850 hasRelatedWork W2346779179 @default.
- W2783603850 hasRelatedWork W2807926821 @default.
- W2783603850 hasRelatedWork W3093951474 @default.
- W2783603850 hasRelatedWork W3123815595 @default.
- W2783603850 hasRelatedWork W3200584320 @default.
- W2783603850 hasRelatedWork W4251032890 @default.
- W2783603850 hasVolume "5" @default.
- W2783603850 isParatext "false" @default.